Voyager Therapeutics Inc reports results for the quarter ended in June - Earnings Summary

Voyager Therapeutics

03/08/2023 14:34

* Voyager Therapeutics Inc  VYGR.OQ  reported a quarterly
adjusted
loss of 51 cents​​ per share for the quarter ended in June. The
mean expectation of eight analysts for the quarter was for a
loss of 57 cents per share.
    * Revenue rose 581.6% to $4.85 million from a year ago;
analysts
expected $1.60 million. 
    * Voyager Therapeutics Inc's reported EPS for the quarter
was a
loss of 51 cents​.
    * The mean earnings estimate of analysts had fallen by
about 38.7%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * Voyager Therapeutics Inc shares had fallen by 21.4% this
quarter and gained 47.5% so far this year.
    * The company reported a quarterly loss of $22.21 million.
    * Wall Street's median 12-month price target for Voyager
Therapeutics Inc is $14.50 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 5 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data
August 3 at 01:34 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2023      -0.57          -0.51          Beat
 Mar. 31 2023      0.77           2.94           Beat
 Dec. 31 2022      -0.55          -0.61          Missed
 Sep. 30 2022      -0.32          0.45           Beat